Buscar
Mostrando ítems 41-50 de 1940
Laboratorio básico en las enfermedades reumáticas más comunesLaboratory Use in the Study of Rheumatic Diseases
(Universidad de Antioquia, Facultad de MedicinaMedellín, Colombia, 2021)
Rheumatic Fever and Rheumatic Heart Disease: Cellular Mechanisms Leading Autoimmune Reactivity and Disease
(SPRINGER/PLENUM PUBLISHERS, 2010)
Rheumatic fever (RF) is an autoimmune disease caused by the gram-positive bacteria Streptococcus pyogenes that follows a nontreated throat infection in susceptible children. The disease manifests as polyarthritis, carditis, ...
Autologous Hematopoietic Stem Cell Transplantation for Childhood Autoimmune Disease
(W B SAUNDERS CO-ELSEVIER INC, 2010)
Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) can be used in the management of patients with autoimmune disorders. Experience gained in adults has helped to better define the conditioning regimens ...
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study
Background The highest number of COVID-19 cases in Italy have been reported in Lombardy, a region in northern Italy.
We aimed to analyse the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection ...
Interleucina-10 e endotelina-1 como biomarcadores de doença valvar reumáticaInterleukin-10 and endothelin-1 as biomarkers of rheumatic valve disease
(DME - Departamento de Medicina – Aracaju - PresencialUniversidade Federal de Sergipe, 2018)
Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke?
(SPRINGER HEIDELBERGHEIDELBERG, 2013-08-02)
To compare clinical and laboratory findings between patients with primary antiphospholipid syndrome (PAPS) versus secondary APS due to rheumatic fever (APS-RF) (according to Jones criteria). Seventy-three APS patients ...
Resource utilization and cost of rheumatic fever
(J Rheumatol Publ Co, 2001-06-01)
Objective. The socioeconomic effects of rheumatic fever (RF) in Brazil, including direct and indirect costs to patients and their families and to society, are largely unknown. We evaluated the utilization of resources and ...